2016 November

Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis

Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis

The presence of amyloid deposits in the brain is one of the major histopathological characteristics of Alzheimer’s disease (AD). The amyloid cascade hypothesis proposes that the amyloid -peptide (Aβ), a major component […]

Cholinesterase Inhibitors

Cholinesterase Inhibitors

The “cholinergic hypothesis” proposes that part of age-related cognitive decline is caused by reduced cerebral cholinergic function. This theory has been used as a rationale for testing drug therapies that restore cholinergic function […]

Mechanisms of vasodilatation

Mechanisms of vasodilatation

Endothelium derived relaxant factors (EDRFs) Endothelium derived relaxant factor is produced and released by the endothelium to cause smooth muscle relaxation. The characterized EDRFs include nitric oxide (NO), prostacyclin (PGI2), and endothelium-derived […]

Types and Treatments of Diabetes mellitus

Types and Treatments of Diabetes mellitus

Diabetes mellitus (DM), commonly referred to as diabetes, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar) levels over a prolonged period, either […]